MediPharm Labs Corp. (TSE:LABS – Get Free Report) shot up 5.9% during trading on Wednesday . The company traded as high as C$0.10 and last traded at C$0.09. 478,567 shares changed hands during trading, an increase of 99% from the average session volume of 241,019 shares. The stock had previously closed at C$0.09.
MediPharm Labs Stock Down 5.6%
The business’s 50 day moving average is C$0.07 and its 200-day moving average is C$0.07. The stock has a market cap of C$36.11 million, a price-to-earnings ratio of -4.25 and a beta of -0.45. The company has a debt-to-equity ratio of 0.56, a quick ratio of 3.10 and a current ratio of 2.77.
About MediPharm Labs
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.
Featured Stories
- Five stocks we like better than MediPharm Labs
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
